Similar articles

• Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.

  Ball SE, Ahern D, Scatina J, Kao J. Ball SE, et al. Br J Clin Pharmacol. 1997 Jun;43(6):619-26. doi: 10.1046/j.1365-2125.1997.00591.x. Br J Clin Pharmacol. 1997. PMID: 9205822 Free PMC article.
• The xenobiotic inhibitor profile of cytochrome P4502C8.

  Ong CE, Coulter S, Birkett DJ, Bhasker CR, Miners JO. Ong CE, et al. Br J Clin Pharmacol. 2000 Dec;50(6):573-80. doi: 10.1046/j.1365-2125.2000.00316.x. Br J Clin Pharmacol. 2000. PMID: 11136296 Free PMC article.
• Biotransformation of losartan to its active carboxylic acid metabolite in human liver microsomes. Role of cytochrome P4502C and 3A subfamily members.

  Stearns RA, Chakravarty PK, Chen R, Chiu SH. Stearns RA, et al. Drug Metab Dispos. 1995 Feb;23(2):207-15. Drug Metab Dispos. 1995. PMID: 7736913
• Inhibition of human cytochrome P450-3A isoforms by fluoxetine and norfluoxetine: in vitro and in vivo studies.

  Greenblatt DJ, von Moltke LL, Schmider J, Harmatz JS, Shader RI. Greenblatt DJ, et al. J Clin Pharmacol. 1996 Sep;36(9):792-8. doi: 10.1002/j.1552-4604.1996.tb04252.x. J Clin Pharmacol. 1996. PMID: 8889899 Review. No abstract available.
• Serotonin selective reuptake inhibitor drug interactions and the cytochrome P450 system.

  Ereshefsky L, Riesenman C, Lam YW. Ereshefsky L, et al. J Clin Psychiatry. 1996;57 Suppl 8:17-24; discussion 25. J Clin Psychiatry. 1996. PMID: 8698676 Review.